Hassan Fred 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Hassan Fred
Director
Transactions
- Award
Stock Options (Right to buy)
2024-09-03+60,000→ 60,000 totalExercise: $8.16Exp: 2034-09-03→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in three ratable annual installments beginning on September 3, 2025.